ah mH Q 08 o oo Pop. ave. dose (cSv) 1 2 { 2 oO > ¢ ost ® 2 0.4} 0.4 & z 0.2 E 0.2 ° = 5 1 86 20 283 ° 0 0.2 0.4 0.6 Population average 30-y Cumulative exposure time (y) 0.8 1 (cSv) Figure 21. Population-average expected dose from hypothetical residence on Rongelap Island starting in 1995 (middle curve) and corresponding two-tail 95% confidence limits on uncertainty in population-average dose, as a function of residence time. 2 w®& SS ® Cumulative probability 10 18 20 2 30 Cumulative exposure time (y) Figure 22. Two-tail 95% confidence limits on “uncertainty in population-average dose from hypothetical residence on Rongelap Island starting in 1995 as ratios of the corresponding expected value of this dose (horizontal line) at specified residence times. o ao 5 ho sos ~~ in Dose/(Expected dose) ~—h cSv and 50th, 95th and 99th perce 0.56, 0.84 and 1.0 cSv, respectively. 025 05 0.75 1 #125 15 Population average lifetime dibse 1.75 2 (cSv) Figure 24. Estimated distribution uncertainty in population-average lifejime dose corresponding to hypothetical resifience of 500 people on Rongelap Island s g in 1995, assuming 40% incur a 70-y exposure {i.e., commencing at birth) and 60% exposure. This distribution has a incur a 30-y and 50th and 95th percentile values of 0.45,0.36 and 1.0 cSv, respectively.